Low dose intravenous immunoglobulins and steroids in toxic epidermal necrolysis: A prospective comparative open-labelled study of 36 cases

Indian Journal of Dermatology, Venereology and Leprology

Volumn 79, Issue 4, 2013, Pages 506-511

  Jagadeesan, Soumya ^a   Sobhanakumari, K ^a   Sadanandan, Sadeep ^a   Ravindran, Sheeba ^a   Divakaran, Manjula ^a   Skaria, Lissy ^a   Kurien, George ^a  

^a Government College   (India)

Author keywords

Combination therapy; Low dose intravenous immunoglobulins; Toxic epidermal necrolysis

Indexed keywords

DEXAMETHASONE; IMMUNOGLOBULIN;

ARTICLE; BODY SURFACE; CLINICAL ARTICLE; COMPARATIVE STUDY; DRUG EFFICACY; EPITHELIZATION; HUMAN; LENGTH OF STAY; LOW DRUG DOSE; MORTALITY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; TOXIC EPIDERMAL NECROLYSIS; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGED; CHILD; COHORT STUDIES; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STEROIDS; STEVENS-JOHNSON SYNDROME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84880159695     PISSN: 03786323     EISSN: 09733922     Source Type: Journal    
DOI: 10.4103/0378-6323.113080     Document Type: Article

References (19)

1. Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998;282: 490-3.
2. Pereira FA, Mudgil AV, Rosmarin DM. Toxic epidermal necrolysis. J Am Acad Dermatol 2007;56: 181-200.
3. Smith DI, Swamy PM, Heffernan MP. Off-label uses of biologics in dermatology: Interferon and intravenous immunoglobulin (part 1 of 2). J Am Acad Dermatol 2007;56: e1-54.
4. Mangla K, Rastogi S, Goyal P, Solanki RB, Rawal RC. Efficacy of low dose intravenous immunoglobulins in children with toxic epidermal necrolysis: An open uncontrolled study. Indian J Dermatol Venereol Leprol 2005;71: 398-400.
5. Habib A, Pasha W, Raza N. Treatment of toxic epidermal necrolysis (TEN) with low dose intravenous immunoglobulin in child. J Coll Physicians Surg Pak 2010;20: 205-7.
6. Tantikul C, Dhana N, Jongjarearnprasert K, Visitsunthorn N, Vichyanond P, Jirapongsananuruk O. The utility of the World Health Organization-The Uppsala Monitoring Centre (WHO-UMC) system for the assessment of adverse drug reactions in hospitalized children. Asian Pac J Allergy Immunol 2008;26: 77-82.
7. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993;129: 92-6.
8. Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: A severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 2000;115: 149-53.
9. Kardaun SH, Jonkman MF. Dexamethasone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis. Acta Derm Venereol 2007;87: 144-8.
10. Pasricha JS. Corticosteroids in toxic epidermal necrolysis. Indian J Dermatol Venereol Leprol 2008;74: 493.
11. Dhar S. Systemic corticosteroids in toxic epidermal necrolysis. Indian J Dermatol Venereol Leprol 1996;62: 270-1.
12. Sharma VK. Guidelines for Stevens Johnson syndrome and Toxic epidermal Necrolysis, and Psoriasis. Delhi: Therapeutic Guidelines Committee IADVL; 2007. p. 7-19.
13. Rütter A, Luger TA. High-dose intravenous immunoglobulins: An approach to treat severe immune-mediated and autoimmune diseases of the skin. J Am Acad Dermatol 2001;44: 1010-24.
14. Metry DW, Jung P, Levy ML. Use of intravenous immunoglobulin in children with stevens-johnson syndrome and toxic epidermal necrolysis: Seven cases and review of the literature. Pediatrics 2003;112: 1430-6.
15. Tristani-Firouzi P, Petersen MJ, Saffle JR, Morris SE, Zone JJ. Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children. J Am Acad Dermatol 2002;47: 548-52.
16. Brown KM, Silver GM, Halerz M, Walaszek P, Sandroni A, Gamelli RL. Toxic epidermal necrolysis: Does immunoglobulin make a difference? J Burn Care Rehabil 2004;25: 81-8.
17. Schneck J, Fagot JP, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study. J Am Acad Dermatol 2008;58: 33-40.
18. Yang Y, Xu J, Li F, Zhu X. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: A retrospective comparative study in China. Int J Dermatol 2009;48: 1122-8.
19. Chen J, Wang B, Zeng Y, Xu H. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: A retrospective study of 82 cases. Eur J Dermatol 2010;20: 743-7.